Search filters

List of works by Jessica C Hassel

Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab

scientific article published on 10 November 2017

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

scientific article published on 29 July 2020

Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.

scientific article

Characterization of arthralgia induced by PD-1 antibody treatment in patients with metastasized cutaneous malignancies.

scientific article

Clinical significance of signs of autoimmune colitis in 18F-fluorodeoxyglucose positron emission tomography-computed tomography of 100 stage-IV melanoma patients

scientific article published on 01 June 2019

First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis

scientific article published on 26 February 2019

Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma

scientific article published on 30 September 2020

Health-related quality of life trajectory of treatment-naive patients with Merkel cell carcinoma receiving avelumab

scientific article published on 17 September 2020

Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders.

scientific article

Longitudinal studies of the 18F-FDG kinetics after ipilimumab treatment in metastatic melanoma patients based on dynamic FDG PET/CT

scientific article published on 05 June 2018

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

scientific article

Predominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell Carcinoma

scientific article published on 13 January 2020

Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanoma.

scientific article published on 20 December 2017

Retrospective Side Effect Profiling of the Metastatic Melanoma Combination Therapy Ipilimumab-Nivolumab Using Adverse Event Data

scientific article published on 31 October 2018

Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy

scientific article (publication date: June 2016)

Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations

scientific article published on 03 October 2019

The outcome of ex vivo TIL expansion is highly influenced by spatial heterogeneity of the tumor T-cell repertoire and differences in intrinsic in vitro growth capacity between T-cell clones

scientific article published on 17 April 2020

The role of interim 18F-FDG PET/CT in prediction of response to ipilimumab treatment in metastatic melanoma.

scientific article published on 24 February 2018